WHC is still in active development. Read this to understand our approach.
depiction of NFLLKCVHYJRNRH-UHFFFAOYSA-N.svg
tripsit

dramamine

Check on tripsit

pubchem

Dimenhydrinate

Check on pubchem

drugmap

Dimenhydrinate

Check on drugmap

wiki

Dimenhydrinate

Check on wiki

Data

InChI: InChI=1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)

Synonyms: NSC-117855,Dimenidrinato [DCIT],DIMENHYDRINATE [HSDB],NCGC00257877-01,CHEBI:94848,Diphenhydramine Theoclate,Gravol,NCGC00021154-07,CCG-40210,Prestwick3_000265,2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione,JB937PER5C,Diphenhydrinate,CHEMBL1200406,[o-Benzhydryl(dimethylamino)ethanol] 8-chlorotheophyllinate,CS-4841,NCGC00091928-03,HSDB 3064,SR-05000001608,DIMENHYDRINATE [VANDF],Dimenhydrinate (JP17/USP/INN),Theohydramine,HMS1920G20,Tox21_200323,Dramyl,Novamin (VAN),Emedyl,Dramamin,Q420439,NSC 117855,DIMENHYDRINATE [MI],DTXSID9025087,1H-Pyrine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1), Dimenhydrinate (JP15/USP/INN),Reidamine,NCGC00021154-06,Novamine,EN300-37158633,SR-05000001608-1,SPECTRUM1500251,Andramine,EINECS 208-350-8,gravol,Aviomarin,FT-0625019,Dramarin,D82297, Vertirosan (TN),Dimenhydrinate, Pharmaceutical Secondary Standard; Certified Reference Material,(o-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate,Dramalen,N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate, Gravol (TN),DIMENHYDRINATE [ORANGE BOOK],Gravinol (antiemetic),Anautine,Spectrum2_000992,s4672,Spectrum3_000397,NCGC00021154-05,NCGC00091928-02,Ethylamine 2-(diphenylmethoxy)-N, compd. with 8-chlorotheophylline (1:1),1H-Purine-2,6-dione, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1),DIMENHYDRINATE [USP-RS],NSC-756740,KBioGR_001093,523D875,2-(diphenylmethoxy)-N,N-dimethylethanamine and 8-chloro-1,3-dimethyl-3,9-dihydro-1H-purine-2,6-dione,Chloranautine,MFCD00054265,HMS2095F12,Permital,KBio2_006590,2-(Diphenylmethoxy)-N,N-dimethylethylamine 8-chlorotheophyllinate,Dimenhydrinate, European Pharmacopoeia (EP) Reference Standard,Dimenidrinato,DIMENHYDRINATE [WHO-DD],DSSTox_GSID_25087,NCI-C60639,HMS3712F12,IDI1_000049,Gravamin (TN),Theophylline, 8-chloro-, compd with 2-(diphenylmethoxy)-N,N-dimethyethylamine (1:1),Dimenhydrinate for peak identification,AS-13166,D00520,Dimenest,Supremal,Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline,Hydrinate,8-Chlorotheophylline, compound with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),KBio3_001433,HY-B1215,BRD-M98649031-001-01-1, 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione-2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1),8-chloro-1,3-dimethyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione; [2-(diphenylmethoxy)ethyl]dimethylamine,KBio2_001454,8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dionecompoundwith2-(benzhydryloxy)-N,N-dimethylethanamine(1:1),Antemin,Spectrum5_000909,Theophylline, 8-chloro-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),SCHEMBL5128,DSSTox_RID_77660,8-Chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione 2-(benzhydryloxy)-N,N-dimethylethanamine salt,dimenhydrinate,Ethylamine, 2-(diphenylmethoxy)-N, N-dimethyl-, compd. with 8-chlorothiophylline (1:1),NCGC00021154-01,KBio2_004022,DSSTox_CID_5087,Xamamina,Dimenhydrinate, United States Pharmacopeia (USP) Reference Standard,Amosyt,Teodramin,Troversin,O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate,DIMENHYDRINATE [INN],Eldodram,Ethylamine 2-(diphenylmethoxy)-N,N-dimethyl-, compd with 8-chlorotheophylline (1:1),Reise-Engletten,NSC756740,BD166163,KBioSS_001454,Dramilin,Diamarin,Dramamine (TN),DivK1c_000049,FT-0696921,Gravinol,Theophylline, compd. with 2-(diphenylmethoxy)-N,N-(dimethylethyl)amine (1:1), 8-chloro-1,3-dimethyl-2-oxopurin-6-olate,Dimenhydrinat,2-(Benzhydryloxy)-N,N-dimethylethylamine 8-chlorotheophyllinate,523-87-5,NCGC00021154-03,Dimenhydrinate for peak identification, European Pharmacopoeia (EP) Reference Standard,CCRIS 4798,Dimenhydrinatum [INN-Latin],Lomarin,Dommanate,Dimentabs,DIMENHYDRINATE [EP IMPURITY],SBI-0051350.P003,BSPBio_002213,SR-05000001608-2,DIMENHYDRINATE [MART.],Neo-Navigan,Faston,Dimenhydrinate,(S),Pharmakon1600-01500251,NINDS_000049,DIMENHYDRINATE [JAN],Ethylamine, N,N-dimethyl-2-(diphenylmethoxy)-, compd. with 8-chlorotheophylline,Dimenhydrinate [USP:INN:BAN:JAN],BPBio1_000122,Diphenhydramine 8-chlorotheophyllinate, 2-benzhydryloxyethyl(dimethyl)azanium, 2-(diphenylmethoxy)-N,N-dimethylethanaminium 8-chloro-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurin-7-ide,Spectrum4_000517,Removine,NCGC00021154-04,Menhydrinate,Spectrum_000974,beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine,SPBio_001083,HMS500C11,DIMENHYDRINATE [USP MONOGRAPH],8-Chlorotheophylline, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),Theophylline, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1),8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione compound with 2-(benzhydryloxy)-N,N-dimethylethanamine (1:1),Dimenhidrinato [INN-Spanish],DB00985,1H-Purine-2, 8-chloro-3,7-dihydro-1,3-dimethyl-, compd. with 2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1),DIMENHYDRINATE [EP MONOGRAPH],Dimate,NSC117855,NCGC00021154-02,AKOS015896341,Travelmin,NCGC00091928-01,HMS2091O08,Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, compd. with 8-chloro-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1),Vomex A,Diphenhydramine 8-chlorotheophylline,Travelin,WLN: T56 BM DN FNVNVJ CG F H &622,AB00053833,2-(Benzhydryloxy)-N,N-dimethylethylamine compd. with 8-chlorotheophylline,UNII-JB937PER5C,KBio1_000049,DIMENHYDRINATE,AC-8241,BSPBio_000110,Dromyl,Dramamine


Estimated data

Solubility: -4.829 (Salt Detected Prediction less reliable) (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 35.9% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.